AR113831A1 - METHODS TO DEACTIVATE A ZIKA VIRUS AND TO DETERMINE TOTAL DEACTIVATION - Google Patents

METHODS TO DEACTIVATE A ZIKA VIRUS AND TO DETERMINE TOTAL DEACTIVATION

Info

Publication number
AR113831A1
AR113831A1 ARP180103213A ARP180103213A AR113831A1 AR 113831 A1 AR113831 A1 AR 113831A1 AR P180103213 A ARP180103213 A AR P180103213A AR P180103213 A ARP180103213 A AR P180103213A AR 113831 A1 AR113831 A1 AR 113831A1
Authority
AR
Argentina
Prior art keywords
methods
deactivate
zika virus
determine total
total deactivation
Prior art date
Application number
ARP180103213A
Other languages
Spanish (es)
Inventor
Jill A Livengood
Holli Giebler
Hansi Dean
Tatsuki Satou
Raman Rao
Jackie Marks
Mark Lyons
Asae Shintani
Jamie Gifford
Original Assignee
Takeda Vaccines Inc
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Vaccines Inc, Us Health filed Critical Takeda Vaccines Inc
Publication of AR113831A1 publication Critical patent/AR113831A1/en

Links

Abstract

Métodos para desactivar un virus de Zika que pueden ser usados en vacunas y composiciones inmunogénicas. Además, un método para determinar que se haya completado la desactivación de una preparación de arbovirus.Methods to inactivate a Zika virus that can be used in vaccines and immunogenic compositions. In addition, a method of determining that the inactivation of an arbovirus preparation has been completed.

ARP180103213A 2017-11-03 2018-11-05 METHODS TO DEACTIVATE A ZIKA VIRUS AND TO DETERMINE TOTAL DEACTIVATION AR113831A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762581500P 2017-11-03 2017-11-03

Publications (1)

Publication Number Publication Date
AR113831A1 true AR113831A1 (en) 2020-06-17

Family

ID=71523240

Family Applications (3)

Application Number Title Priority Date Filing Date
ARP180103214A AR113832A1 (en) 2017-11-03 2018-11-05 VACCINES AGAINST ZIKA, IMMUNOGENIC COMPOSITIONS AND METHODS USING THEM
ARP180103216A AR117942A1 (en) 2017-11-03 2018-11-05 VACCINES AGAINST ZIKA, IMMUNOGENIC COMPOSITIONS AND METHODS USING THEM
ARP180103213A AR113831A1 (en) 2017-11-03 2018-11-05 METHODS TO DEACTIVATE A ZIKA VIRUS AND TO DETERMINE TOTAL DEACTIVATION

Family Applications Before (2)

Application Number Title Priority Date Filing Date
ARP180103214A AR113832A1 (en) 2017-11-03 2018-11-05 VACCINES AGAINST ZIKA, IMMUNOGENIC COMPOSITIONS AND METHODS USING THEM
ARP180103216A AR117942A1 (en) 2017-11-03 2018-11-05 VACCINES AGAINST ZIKA, IMMUNOGENIC COMPOSITIONS AND METHODS USING THEM

Country Status (1)

Country Link
AR (3) AR113832A1 (en)

Also Published As

Publication number Publication date
AR117942A1 (en) 2021-09-08
AR113832A1 (en) 2020-06-17

Similar Documents

Publication Publication Date Title
MX2020004542A (en) Method for inactivating zika virus and for determining the completeness of inactivation.
PH12018500127A1 (en) Vaccine compositions
AR110684A1 (en) COMPOSITIONS THAT INCLUDE BACTERIAL VINTAGES AND TREATMENT METHOD
PH12018000197A1 (en) Hand, foot, and mouth vaccines and methods of manufacture and use thereof
CL2015001111A1 (en) Adjuvant composition comprising a carbohydrate attached to the chitosan forming a schiff base; vaccine formulation that comprises it; elaboration method; and use of the vaccine.
AR102547A1 (en) VACCINES AGAINST DISEASE OF HANDS, FEET AND MOUTH AND MANUFACTURING METHODS AND THEIR USE
PE20181135A1 (en) PROCESS FOR PREPARING A TETRAVALENT VACCINE AGAINST DENGUE VIRUS
MX2022013912A (en) Novel methods for inducing an immune response.
SG11202004863QA (en) Zika vaccines and immunogenic compositions, and methods of using the same
AR089995A1 (en) ROTAVIRUS SUBUNITIES VACCINES, METHODS OF PREPARATION AND USE OF THE SAME
CO2018002207A2 (en) Compositions against cat allergy
EA201890502A1 (en) COMBINED VACCINE COMPOSITION FOR MULTIPLE DOSING
AR104271A1 (en) VACCINE AGAINST PAPERAS BASED ON VIRUS JERYL LYNN 2 RECOMBINANT
AR113831A1 (en) METHODS TO DEACTIVATE A ZIKA VIRUS AND TO DETERMINE TOTAL DEACTIVATION
EA201991319A1 (en) VACCINES OF ATTENUATED SWINE INFLUENZA AND METHODS OF THEIR MANUFACTURE AND APPLICATION
AR095118A1 (en) A COMPOSITION VIRAL INACTIVATION PROCEDURE THAT INCLUDES FACTOR VII
WO2018175580A3 (en) Development of an alternative modified live influenza b virus vaccine
MX2018011226A (en) Tc24-c4, a chagas disease vaccine antigen with improved stability and decreased aggregation.
UA92404U (en) Method for inactivation of infectious properties of haemagglutinating viruses
CL2022001176A1 (en) Compositions and methods for producing a reduced particle size viral vaccine
CL2017003506A1 (en) A composition of an immunostimulant product for farmed fish, a formulation comprising the composition, a method for preparing said composition, and use of the composition and formulation.
AR109026A1 (en) COMPOSITIONS THAT INCLUDE BACTERIAL VINTAGES
EA201892348A1 (en) COMBINATIONS AND METHODS INCLUDING THE CAPSIDE ASSEMBLY INHIBITOR
ZA201700164B (en) Influenza virus vaccines and uses thereof
RU2014146753A (en) The method of exposure to anisic lofant on hypercholesterolemia